Articles On Alcidion Group (ASX:ALC)

It’s been a rough year for investors of small-cap ASX shares. “All types of investing require nerve and courage. But perhaps none more so than small-cap stocks,” said Ophir analysts in a memo to investors this month. “When an economic down...

The Dubber Corp Ltd (ASX: DUB) share price will emerge from the ASX suspension on Monday. I’m guessing the Dubber share price will be punished. For context, I wrote last week why Dubber shares were suspended. I have no dog in this fight — f...

Claude Walker is the founder of A Rich Life and a small-cap investing expert. Claude joins Owen Rask on The Australian Investors Podcast to help us understand where we might be in the market cycle, and the duo identifies two of their favour...

The Australian Investors Podcast welcomes back Claude Walker, founder of A Rich Life, to talk about 5 companies that caught his eye during ASX Reporting Season, including Objective Corporation Ltd (ASX: OCL), PWR Holdings (ASX: PWH) and mor...

Dubber Corp Ltd (ASX: DUB), Alcidion Group Ltd (ASX: ALC), Fortescue Metals Group Ltd (ASX: FMG) and Wesfarmers Ltd (ASX: WES) feature on this week’s Australian Investors Podcast. Drew Meredith, CFP and Owen Rask are back on The Australian...

This week, we bid farewell to winter… and another tumultuous ASX earnings season. So now, looking ahead to the brighter days of spring, hopefully the stock market can also deliver some healthy new growth. Armed with a barrow full of inf...

The All Ordinaries Index (ASX: XAO) is in the green so far today. At the time of writing, it’s 0.52% higher at 7,231 points. Earnings season has been a busy one with plenty of mixed results. Here are three ASX All Ordinaries standouts that...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. At the time of writing, the benchmark index is up a fraction to 6,810.2 points. Four ASX shares that are climbing more than most tod...

The Alcidion Group Ltd (ASX: ALC) share price has been a strong performer on Wednesday. In afternoon trade, the healthcare technology company’s shares are up over 18% to 16 cents. This follows the release of Alcidion’s unaudited fourth...

Digital healthcare company Alcidion (ALC) achieves record quarterly cash receipts of $14 million for the June quarter Total cash receipts for FY22 came to $41.4 million, a 29 per cent increase on the prior year, resulting in positive opera...

Ask A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Cyan Investment Management portfolio manager Dean Fergie nominates a bargain ASX share...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Fears of rising interest rates have really taken their toll on growth and small-cap ASX shares. That’s because smaller, rapidly expanding businesses are typically the ones who have taken on debt to fuel their growth. And when a company bor...

This year has been a rough ride for most ASX shares, but small-cap companies have suffered more than their larger cousins. The Cyan C3G Fund, which specialises in small-cap stocks, has felt the pain as much as any retail investor. Portfoli...

Dean Fergie, is the co-founder of Melbourne-based Cyan Investment, where his 25 years in funds management across all major asset classes is poured into one single fund. Dean has absolutely no intention of being all things to all people. “We...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

In this episode of The Australian Investors Podcast, Owen Rask is joined by 7Investing’s Dr Anirban Mahanti to talk markets, the economy, how to value tech stocks and more. Stocks mentioned in the podcast include: Target Corporation (NYSE...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Are you the cuddly type?...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. Here’s why these small cap ASX shares could be worth adding to your watchlist: Adore Beauty...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Highlights The benchmark index ASX200 was down 0.817% at 7258.200 points at 3:22 PM AEST on Wednesday (27 April 2022). The S&P/ASX 200 Health Care Index (ASX:XHJ) was 1.380% lower at 40598.200 points during the intraday trading ses...

Digital healthcare company Alcidion Group (ALC) says the March quarter was a “very strong” period for the company Alcidion earned $12.5 million in new sales which contributed to nearly $43 million in year-to-date sales At the end of the th...

Alcidion (ASX:ALC) signs an agreement with Northern Territory Health (NT Health) that will see NT Health upgrade from an earlier version of Miya to Alcidion’s current Miya Precision platform NT Health will deploy the latest Miya Precision...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Cann will market its CBD capsules in Australia 4DMedical’s XV LVAS software is being trialed in a hospital in California Polynovo’s record March quarter Cann to market CBD capsules in Australia Cannabis company Cann Group (ASX:CAN) has en...

Digital medical information specialist Alcidion (ALC) signs a five-year agreement with East Lancashire Hospitals NHS Trust in the UK to implement the company’s Miya Precision, an upgrade to the existing ExtraMed patient flow solution The c...

Wall Streeet tumbled overnight on US Fed comments  Fed Governor Lael Brainard said the Fed will start reducing the Fed’s balance sheet in May Bond market also sold off ASX to slide as Wall Street tumbles Local shares are poised to fall to...

Alcidion Group (ALC) signs contract renewal agreements with existing customers Moorfields Eye Hospital and Liverpool Heart and Chest Hospital for the use of its Silverlink Patient Care System (PCS) solution Both hospitals are committing to...

Alcidion (ALC) signs a five-year agreement with Dartford and Gravesham NHS Trust to implement the company’s new Miya Emergency module The two software products are expected to alleviate pressure while focusing priorities for emergency dep...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

ASX Emerging Companies (XEC) index has closed 1.5% on Tuesday Index now over 10% the better since February 22 Tuesday winners: ResApp (ASX:RAP), RiversGold (ASX:RGL)    The ASX Emerging Companies (XEC) index is 1.5% higher in late trade....

Alcidion (ALC) strikes a $1.35 million deal to supply its Miya Flow technology to Herefordshire and Worcestershire Health and Care NHS Trust for five years The NHS trust will deploy the tech across six community hospitals to streamline pat...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Cyan Investm...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Alcidion Group (ALC) signs a five-year agreement with the NHS Tayside with the NHS Tayside health board in Scotland to deploy its Miya Observations and Assessments solution The company says NHS Tayside is the third health board in Scotland...

With all the crazy events going on around the world, many ASX shares have been hammered this year regardless of how the underlying business is going. And that’s exactly the disappointment Cyan portfolio manager Dean fergie relayed to his...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Investing in the small side of the share market carries more risk than other areas. However, if your risk tolerance allows for it, having a bit of exposure to this side of the market could be a good thing for a balanced portfolio given the...

Healthcare technology company Alcidion (ALC) says the first half of FY22 was a “transformational” period for its business The company expanded its market share within the British NHS to 26 per cent with acquisition of Silverlink which was...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, SG Hiscock portfolio manager Rory Hunter reveals the 2 medical tech ASX shares that will reward t...

The small end of the Australian share market is home to a number of companies with the potential to grow materially in the future. Four that investors might want to get better acquainted with are listed below. Here’s why they should be on...

Are you looking to add a small cap share or two to your portfolio in the near future? If you are, then you might want to consider one of the ASX shares listed below. Here’s what you need to know about these exciting small cap shares: Alcid...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been given buy ratings and tipped for big things in the future. Here’s what y...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

2021 has been nothing if not eventful. And now, some may say gleefully, it is finally drawing to a close. To celebrate the approaching new year, we asked our Foolish contributors to compile a list of some of the ASX shares experts are sayi...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...